ENTRESTO 15 mg/16 mg, granulés en gélule à ouvrir — plaquette(s) polyamide aluminium PVC de 60 gélule(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930277133 -
CIP7
3027713 -
CIS
61428656 -
Registration number
EU/1/15/1058
What the source publishes
- Holder
- NOVARTIS EUROPHARM (IRLANDE)
- Active ingredients
- VALSARTAN, COMPLEXE SODIQUE SACUBITRIL VALSARTAN HÉMIPENTAHYDRATÉ, SACUBITRIL
- Form
- granulés en gélule
- Package
- plaquette(s) polyamide aluminium PVC de 60 gélule(s)
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- liste I
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2023-05-26
- Prescription
- Prescription or restricted
Names this record is found by
- ENTRESTO 15 mg/16 mg, granulés en gélule à ouvrir — plaquette(s) polyamide aluminium PVC de 60 gélule(s)
- ENTRESTO 15 mg/16 mg, granulés en gélule à ouvrir
- VALSARTAN
- COMPLEXE SODIQUE SACUBITRIL VALSARTAN HÉMIPENTAHYDRATÉ
- SACUBITRIL
Complete source data
{
"cis": "61428656",
"cip7": "3027713",
"form": "granulés en gélule",
"name": "ENTRESTO 15 mg/16 mg, granulés en gélule à ouvrir — plaquette(s) polyamide aluminium PVC de 60 gélule(s)",
"cip13": "3400930277133",
"holder": "NOVARTIS EUROPHARM (IRLANDE)",
"routes": [
"orale"
],
"holders": [
"NOVARTIS EUROPHARM (IRLANDE)"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "118.86",
"authorisedOn": "2023-05-26",
"compositions": [
{
"name": "VALSARTAN",
"nature": "FT",
"strength": "16,07 mg",
"linkageNumber": "1",
"substanceCode": "15734",
"dosageReference": "une gélule",
"pharmaceuticalElement": "granulés"
},
{
"name": "COMPLEXE SODIQUE SACUBITRIL VALSARTAN HÉMIPENTAHYDRATÉ",
"nature": "SA",
"strength": null,
"linkageNumber": "1",
"substanceCode": "16541",
"dosageReference": null,
"pharmaceuticalElement": "granulés"
},
{
"name": "SACUBITRIL",
"nature": "FT",
"strength": "15,18 mg",
"linkageNumber": "1",
"substanceCode": "78789",
"dosageReference": "une gélule",
"pharmaceuticalElement": "granulés"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "liste I",
"dispensingFee": "1.02",
"medicinePrice": "117.84",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "ENTRESTO 15 mg/16 mg, granulés en gélule à ouvrir",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "plaquette(s) polyamide aluminium PVC de 60 gélule(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"65 %"
],
"marketingDeclaredOn": "2024-07-15",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"VALSARTAN",
"COMPLEXE SODIQUE SACUBITRIL VALSARTAN HÉMIPENTAHYDRATÉ",
"SACUBITRIL"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"liste I"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/15/1058",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930277133"